Camden National (CAC) Q4 2025 earnings review
Record Earnings Driven by Margin Expansion, Despite Loan Contraction
Camden National (CAC) closed FY25 with record quarterly earnings of $22.6 million (+6% QoQ), fueled by significant Net Interest Margin (NIM) expansion and disciplined expense management. The integration of Northway Financial is fully accretive, evidenced by the non-GAAP efficiency ratio improving to 51.7%. However, balance sheet momentum stalled: total loans contracted 1% sequentially as commercial balances declined, offsetting strength in home equity. While credit noise persists (a $3.0M CRE short sale), the overall asset quality metrics improved. Management signaled confidence by announcing a 5% share repurchase program.
🐂 Bull Case
NIM expanded 13 basis points QoQ to 3.29%, driven by an 11 basis point reduction in funding costs. As rates decline, CAC's liability-sensitive balance sheet is capturing spread faster than peers.
The post-Northway integration is delivering tangible results. The non-GAAP efficiency ratio improved significantly to 51.69% in Q4 from 58.22% a year ago, demonstrating strong operating leverage.
🐻 Bear Case
Total loans fell 1% QoQ, driven by a $62M decline in Commercial balances. While Home Equity is growing (+6%), the core commercial engine decelerated significantly from the 4% annualized growth seen in Q3.
While non-performing assets dropped, the quarter included a $3.2M net charge-off event related to a CRE short sale. While management calls this 'prudent,' it indicates pockets of stress within the CRE portfolio.
⚖️ Verdict: 🟢
Bullish. The bank is executing perfectly on the metrics that control profitability (NIM and Efficiency). The ability to expand margins by 13bps while lowering funding costs validates the balance sheet strategy. The loan contraction is a watch item, but the earnings power generated by the Northway acquisition is now fully visible and accretive.
Key Themes
Net Interest Margin Acceleration
Accelerating. NIM expanded 13 basis points sequentially to 3.29%, accelerating from the 10bps expansion in Q3. The driver is clear: funding costs fell 11 basis points in the quarter. This confirms the bank's liability sensitivity is paying off as interest rates stabilize or decline, allowing them to reprice deposits faster than assets yield.
Commercial Loan Runoff
Reversing. After showing 4% annualized growth in Q3, total loans contracted 1% in Q4. The primary culprit was the Commercial portfolio, which fell $62M (driven by a $35.9M drop in municipal loans). This reversal suggests softening demand or intentional runoff of lower-yielding assets, dragging on top-line asset growth.
Efficiency & Northway Synergies
Accelerating. The non-GAAP efficiency ratio hit 51.69%, a massive improvement from 58.22% a year ago. This confirms the cost synergies from the Northway acquisition (closed Jan 2025) have been fully realized and exceeded initial expectations of ~35% cost saves.
CRE Portfolio Clean-up
Management proactively exited a large classified CRE loan via a short sale, resulting in a $3.0M charge-off. While this spiked the net charge-off ratio to an annualized 0.26% (vs 0.04% typically), it successfully reduced Non-Performing Assets to a pristine 0.10% of total assets. This effectively 'clears the deck' for 2026.
Home Equity Strength
Accelerating. While commercial lending faltered, Home Equity loans grew 6% sequentially and 18% organically for the full year. This indicates strong consumer demand in their Northern New England footprint and successful cross-selling to the acquired customer base.
Capital Returns
Stable. The company announced a new share repurchase program on January 8, 2026, for up to 850,000 shares (~5% of outstanding). With Tangible Book Value up 4% QoQ to $29.69, the bank has the capital flexibility to support the stock price.
Other KPIs
Accelerating. Up 6% from $1.25 in Q3 and up 33% from $1.00 in 24Q4. Full year non-GAAP EPS of $4.39 rose 20% YoY.
Stable/Rising. Increased 4% sequentially from $28.42 in Q3. This metric has recovered significantly from the acquisition-related dilution early in the year.
Stable. Maintained the high level achieved in Q3 (19.12%), significantly above the 13.5% reported in 24Q4.
Guidance
New authorization announced Jan 8, 2026, representing ~5% of outstanding stock. No specific timeline given, but signals confidence in valuation.
No specific numeric guidance provided in the press release. Management stated generally they are 'positioned for an outstanding 2026.'
Key Questions
Commercial Loan Contraction Drivers
Commercial loan balances declined $62M QoQ, driven heavily by municipal loans. Was this a strategic exit from lower-yielding assets to protect NIM, or a sign of weakening demand in the New Hampshire/Maine markets?
NIM Peak vs. Plateau
NIM expanded 13bps this quarter largely due to falling funding costs. How much further can deposit costs reprice downward in Q1/Q2 2026, and should we expect NIM expansion to moderate or continue at this pace?
CRE Stress Test
Regarding the $3.0M charge-off on the CRE short sale: Are there other similar classified assets in the portfolio that might require similar exits in early 2026, or was this a unique, isolated credit?
Expense Run Rate
Non-interest expense ticked up slightly to $36.9M in Q4 due to incentives and tech costs. Is this ~$37M level the new baseline run-rate for 2026, or can we expect further efficiency improvements?